CompletedNCT00153491

Adherence to Lumefantrine-Artemether

Studying Malaria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
Louise Causer, MBBS, MScPH
Centers for Disease Control and Prevention
Intervention
artemether-lumefantrine(drug)
Enrollment
300 enrolled
Eligibility
0 years · All sexes
Timeline
20022006

Study locations (1)

Collaborators

Ifakara Health Research and Development Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00153491 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria

← Back to all trials